PT  - JOURNAL ARTICLE
AU  - Juárez-Flores, Arturo
AU  - Ascencio-Montiel, Iván J.
AU  - Gutiérrez, Juan Pablo
AU  - Bertozzi, Stefano M.
AU  - Borja-Aburto, Víctor H.
AU  - Olaiz, Gustavo
TI  - COVID-19 in the Mexican Social Security Institute (IMSS) population. Prevalent symptoms
AID  - 10.1101/2022.04.12.22273734
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.12.22273734
4099  - http://medrxiv.org/content/early/2022/04/16/2022.04.12.22273734.short
4100  - http://medrxiv.org/content/early/2022/04/16/2022.04.12.22273734.full
AB  - Background The disease caused by the new coronavirus SARS-CoV-2, COVID-19, which appeared in early 2020 in Mexico, was the second leading cause of mortality in the country that year and has generated an increasing demand for medical care. By January 2022, 4.13 million cases and 300 thousand direct deaths have been documented.Objective To describe the main symptoms of people with a positive test for SARS-CoV-2 treated at the Mexican Institute of Social Security (IMSS) by sex, age group, and IMSS delegation.Methods 4.5 million epidemiological reports were registered in the IMSS epidemiological surveillance system between February 2020 and November 2021. They were analyzed, reporting for those with either a positive PCR or rapid test, the prevalence of symptoms by sex, groups of age, and IMSS delegation.Results Among the population treated at the IMSS, six symptoms are observed as the most prevalent in general, as well as by sex, age groups, and state of residence: cefalea, fever, cough, myalgia, odynophagia, and arthralgias.Conclusions A better understanding of the clinical picture with which confirmed cases of COVID-19 present contributes to reporting timely diagnoses, considering the particularities by sex, age, and place of residence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite de Etica en Investigacion en Salud, Instituto Mexicano del Seguro Social. Comite de Etica en Investigacion de la Facultad de MedicinaI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the auth